Brief: Biora Therapeutics Inc Receives Notice Of Delisting From Nasdaq
20/01/2023 21:09
Jan 20 (Reuters) - Biora Therapeutics Inc BIOR.O :
* BIORA THERAPEUTICS INC - ON JANUARY 19, 2023, CO RECEIVED
NOTICE
OF DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR
STANDARD FROM NASDAQ
Source: (shorturl.at/arSW8)
Further company coverage: BIOR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biora Therapeutics
See all newsBiora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Brief: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules